Teva Pharmaceutical Industries Ltd TEVA
1,000 filings, 20 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 78 events
- Nov 12, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 20,003 shares worth about $856KForm 144, approximate sale date Nov 11, 2026
- Nov 12, 2026 Planned sale Sabag Mark (Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL) gave notice of a planned sale of 44,710 shares worth about $2.0MForm 144, approximate sale date Nov 12, 2026
- Nov 10, 2026 Planned sale Francis Richard D. (Officer) gave notice of a planned sale of 250,000 shares worth about $10.7MForm 144, approximate sale date Nov 10, 2026, under a 10b5-1 plan adopted Jun 15, 2026
- Nov 9, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 25,000 shares worth about $1.1MForm 144, approximate sale date Nov 9, 2026
- Nov 5, 2026 Planned sale Sabag Mark (Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL) gave notice of a planned sale of 46,000 shares worth about $1.9MForm 144, approximate sale date Nov 5, 2026
- Nov 4, 2026 Planned sale Bergwerk Dov (Senior VP General Counsel Corporate Secretary) gave notice of a planned sale of 26,260 shares worth about $1.1MForm 144, approximate sale date Nov 4, 2026
- Nov 3, 2026 Planned sale Christine Fox (EVP, U.S. Commercial) adopted a 10b5-1 trading planreported in the 10-Q, up to 63,492 shares, runs to Nov 21, 2026
- Nov 3, 2026 Planned sale Matthew Shields (EVP, Teva Global Operations) adopted a 10b5-1 trading planreported in the 10-Q, up to 171,410 shares, runs to Jun 5, 2027
- Nov 3, 2026 Planned sale Dr. Eric Hughes (EVP, Global R&D and Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 266,477 shares, runs to Mar 8, 2027
- Nov 3, 2026 8-K Quarterly results8-K item 2.02
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 29, 2026 8-K Director or officer change8-K item 5.02
- Sep 21, 2026 Planned sale Savage Brian (Officer, CHIEF LEGAL OFFICER) gave notice of a planned sale of 7,028 shares worth about $273KForm 144, approximate sale date Sep 18, 2026
- Sep 18, 2026 Planned sale Bridger Management, LLC (1) (Shareholder) gave notice of a planned sale of 367,600 shares worth about $14.4MForm 144, approximate sale date Sep 18, 2026
- Sep 16, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Sep 14, 2026 8-K Other events8-K item 8.01
- Sep 11, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Sep 3, 2026 8-K Shareholder rights changed8-K item 3.03
- Sep 3, 2026 8-K Other events8-K item 8.01
- Aug 17, 2026 Planned sale Lippman Evan (Officer, EVP BUSINESS DEVELOPMENT) gave notice of a planned sale of 18,600 shares worth about $680KForm 144, approximate sale date Aug 17, 2026, under a 10b5-1 plan adopted May 16, 2026
- Aug 3, 2026 Planned sale Jover Placid (Executive VP, Chief HR Officer) gave notice of a planned sale of 12,827 shares worth about $447KForm 144, approximate sale date Aug 3, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Aug 3, 2026 Planned sale Hughes Eric A (Executive VP Global R&D and Chief Med Officer) gave notice of a planned sale of 25,578 shares worth about $892KForm 144, approximate sale date Aug 3, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Jul 29, 2026 8-K Quarterly results8-K item 2.02
- Jul 29, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 18, 2026 Planned sale Shields Matthew (Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS) gave notice of a planned sale of 9,989 shares worth about $322KForm 144, approximate sale date Jun 18, 2026
- Jun 11, 2026 Planned sale Kalif Eliyahu Sharon (Officer, EVP CHIEF FINANCIAL OFFICER) gave notice of a planned sale of 106,563 shares worth about $3.6MForm 144, approximate sale date Jun 11, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Jun 5, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 6,153 shares worth about $211KForm 144, approximate sale date Jun 5, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Jun 3, 2026 Planned sale Shields Matthew (Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS) gave notice of a planned sale of 16,195 shares worth about $532KForm 144, approximate sale date Jun 3, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- May 28, 2026 8-K Shareholder vote results8-K item 5.07
- May 14, 2026 Planned sale Kalif Eliyahu Sharon (Officer, EVP CHIEF FINANCIAL OFFICER) gave notice of a planned sale of 153,251 shares worth about $5.5MForm 144, approximate sale date May 14, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- May 14, 2026 Planned sale Lippman Evan (Officer, EXECUTIVE VP BUSINESS DEVELOPMENT) gave notice of a planned sale of 41,658 shares worth about $1.5MForm 144, approximate sale date May 14, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- May 5, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 30,000 shares worth about $1.1MForm 144, approximate sale date May 5, 2026
- May 4, 2026 Planned sale Sabag Mark (Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL) gave notice of a planned sale of 144,180 shares worth about $5.0MForm 144, approximate sale date May 1, 2026
- Apr 30, 2026 Planned sale Christine Fox (Officer) gave notice of a planned sale of 21,258 shares worth about $751KForm 144, approximate sale date Apr 30, 2026
- Apr 29, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Apr 29, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Mar 17, 2026 Planned sale Sabag Mark (Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL) gave notice of a planned sale of 62,102 shares worth about $1.9MForm 144, approximate sale date Mar 17, 2026
- Mar 5, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 17,295 shares worth about $548KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 5, 2026 Planned sale Hughes Eric A (Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER) gave notice of a planned sale of 9,533 shares worth about $302KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 5, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 20,025 shares worth about $634KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Mar 5, 2026 Planned sale Fox Christine (Officer, EVP HEAD OF US COMMERCIAL) gave notice of a planned sale of 7,924 shares worth about $251KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Mar 5, 2026 Planned sale Savage Brian (Officer, INTERIM CHIEF LEGAL OFFICER) gave notice of a planned sale of 1,127 shares worth about $36KForm 144, approximate sale date Mar 5, 2026
- Mar 5, 2026 Planned sale Jover Placid (Officer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER) gave notice of a planned sale of 14,150 shares worth about $448KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Aug 10, 2025
- Mar 5, 2026 Planned sale Shields Matthew (Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS) gave notice of a planned sale of 17,295 shares worth about $548KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Aug 10, 2025
- Mar 4, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 91,345 shares worth about $3.0MForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 4, 2026 Planned sale Hughes Eric A (Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER) gave notice of a planned sale of 11,277 shares worth about $366KForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 4, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 23,393 shares worth about $759KForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Mar 4, 2026 Planned sale Fox Christine (Officer, EVP HEAD OF US COMMERCIAL) gave notice of a planned sale of 9,908 shares worth about $322KForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Mar 3, 2026 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 128,985 shares worth about $4.2MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 3, 2026 Planned sale Hughes Eric A (Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER) gave notice of a planned sale of 80,762 shares worth about $2.6MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 10, 2025
- Mar 3, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 442,935 shares worth about $14.3MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Mar 3, 2026 Planned sale Savage Brian (Officer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER) gave notice of a planned sale of 1,274 shares worth about $41KForm 144, approximate sale date Mar 3, 2026
- Feb 26, 2026 Planned sale Kalif Eliyahu Sharon (Officer, EVP CHIEF FINANCIAL OFFICER) gave notice of a planned sale of 345,810 shares worth about $11.6MForm 144, approximate sale date Feb 26, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Feb 18, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 447,778 shares worth about $15.3MForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Feb 18, 2026 Planned sale Francis Richard D (Officer, PRESIDENT AND CEO) gave notice of a planned sale of 447,778 shares worth about $448KForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Feb 3, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 28, 2026 8-K Quarterly results8-K item 2.02
- Jan 12, 2026 8-K Quarterly results8-K item 2.02
- Dec 12, 2025 Planned sale Bridger Management, LLC (1) (Shareholder) gave notice of a planned sale of 150,000 shares worth about $4.5MForm 144, approximate sale date Dec 12, 2025
- Dec 11, 2025 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Dec 9, 2025 Planned sale Daniell Richard (Officer, EXECUTIVE VP EUROPEAN COMMERCIAL) gave notice of a planned sale of 115,468 shares worth about $3.3MForm 144, approximate sale date Dec 9, 2025
- Dec 9, 2025 Planned sale Sabag Mark (Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL) gave notice of a planned sale of 216,892 shares worth about $6.2MForm 144, approximate sale date Dec 9, 2025
- Nov 26, 2025 Planned sale Bridger Management, LLC (1) (Shareholder) gave notice of a planned sale of 50,000 shares worth about $1.2MForm 144, approximate sale date Nov 26, 2025
- Nov 20, 2025 Planned sale Fox Christine (Officer, EVP HEAD OF US COMMERCIAL) gave notice of a planned sale of 28,229 shares worth about $700KForm 144, approximate sale date Nov 20, 2025, under a 10b5-1 plan adopted Aug 11, 2025
- Nov 14, 2025 Planned sale Fox Christine (Officer, EVP HEAD OF US COMMERCIAL) gave notice of a planned sale of 30,000 shares worth about $753KForm 144, approximate sale date Nov 14, 2025
- Nov 5, 2025 8-K Quarterly results8-K item 2.02
- Nov 5, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Jul 30, 2025 8-K Quarterly results8-K item 2.02
- Jul 30, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 5, 2025 8-K Shareholder vote results8-K item 5.07
- May 28, 2025 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- May 22, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- May 7, 2025 8-K Quarterly results8-K item 2.02
- May 7, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 28, 2025 SEC letter SEC asked 1 question about Form 10-K for the Fiscal Year Ended December 31, 2024letters Apr 7, 2025 to Apr 28, 2025 · Non-GAAP measures, Liquidity and cash
- Feb 7, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · may offer and sell from time to time: • American Depositary Shares (“ADSs”), each representing one ordinary share; senior or subordinated debt securities; purchase contracts; and units.
- Feb 5, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 29, 2025 8-K Quarterly results8-K item 2.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 12, 2026 | 144 | Notice of planned insider sale |
| Nov 12, 2026 | 144 | Notice of planned insider sale |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 3 | New insider |
| Nov 10, 2026 | 144 | Notice of planned insider sale |
| Nov 10, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 9, 2026 | 144 | Notice of planned insider sale |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 5, 2026 | 144 | Notice of planned insider sale |
| Nov 4, 2026 | 144 | Notice of planned insider sale |
| Nov 3, 2026 | 8-K | Quarterly results |
| Nov 3, 2026 | 10-Q | Quarterly report |
| Nov 2, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 29, 2026 | 8-K | Director or officer change |
| Oct 8, 2026 | 3 | New insider |
| Sep 22, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 4 | Insider trade |
| Sep 21, 2026 | 144 | Notice of planned insider sale |
| Sep 18, 2026 | 144 | Notice of planned insider sale |
| Sep 16, 2026 | 8-K | Material agreement signed, New debt or obligation |
| Sep 14, 2026 | 8-K | Other events |
| Sep 14, 2026 | 8-A12B/A | |
| Sep 14, 2026 | 25-NSE | |
| Sep 11, 2026 | 424B5 | Prospectus |
| Sep 11, 2026 | 8-K | Regulation FD disclosure, Other events |
| Sep 10, 2026 | FWP | Offering terms |
| Sep 10, 2026 | FWP | Offering terms |
| Sep 8, 2026 | 424B5 | Prospectus |
| Sep 3, 2026 | 8-K | Other events |
| Sep 3, 2026 | 8-K | Shareholder rights changed |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 19, 2026 | 4 | Insider trade |
| Aug 17, 2026 | 144 | Notice of planned insider sale |
| Aug 10, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 144 | Notice of planned insider sale |
| Aug 3, 2026 | 144 | Notice of planned insider sale |
| Jul 29, 2026 | F-6 POS | |
| Jul 29, 2026 | 10-Q | Quarterly report |
| Jul 29, 2026 | 8-K | Quarterly results |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 144 | Notice of planned insider sale |
| Jun 16, 2026 | 4 | Insider trade |
| Jun 11, 2026 | 144 | Notice of planned insider sale |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 144 | Notice of planned insider sale |
| Jun 4, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 144 | Notice of planned insider sale |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| May 28, 2026 | 8-K | Shareholder vote results |
| May 18, 2026 | 4 | Insider trade |
| May 18, 2026 | 4 | Insider trade |
| May 14, 2026 | 144 | Notice of planned insider sale |
| May 14, 2026 | 144 | Notice of planned insider sale |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 5, 2026 | 144 | Notice of planned insider sale |
| May 4, 2026 | 144 | Notice of planned insider sale |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| Apr 30, 2026 | 144 | Notice of planned insider sale |
| Apr 29, 2026 | 10-Q | Quarterly report |
| Apr 29, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Mar 31, 2026 | DEFA14A | Extra proxy material |
| Mar 31, 2026 | ARS | Annual report to shareholders |
| Mar 31, 2026 | DEF 14A | Proxy statement |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 144 | Notice of planned insider sale |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.